MLchartDataset catalogue

WT1 mRNA-electroporated autologous dendritic cell vaccine

Term · Oncology and biomedicine · MLC-T-ONC-017578

A cancer vaccine containing autologous dendritic cells electroporated with full-length mRNA encoding Wilms' tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1 mRNA-electroporated autologous dendritic cell vaccine may elicit a cytotoxic T-cell (CTL) response against tumor cells expressing WT1. Wt1 is frequently overexpressed in a variety of tumor cell types and often correlates with disease progression and poor prognosis.

Table 1. Record
IdentifierMLC-T-ONC-017578
FieldOncology and biomedicine
SynonymsWilms tumor 1 mRNA-electroporated autologous dendritic cell vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017578",
  "term": "WT1 mRNA-electroporated autologous dendritic cell vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine containing autologous dendritic cells electroporated with full-length mRNA encoding Wilms' tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1 mRNA-electroporated autologous dendritic cell vaccine may elicit a cytotoxic T-cell (CTL) response against tumor cells expressing WT1. Wt1 is frequently overexpressed in a variety of tumor cell types and often correlates with disease progression and poor prognosis.",
  "synonyms": [
    "Wilms tumor 1 mRNA-electroporated autologous dendritic cell vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/wt1-mrna-electroporated-autologous-dendritic-cell-vaccine/"
}

Record 17,463 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.